Atlas Trials

Sheng Zhang

4 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Sheng Zhang

RecordFirmDate
Trastuzumab Rezetecan in Advanced Solid Tumors Refractory to Standard Therapies (NCT07309770)Sheng Zhang2025-12-18
Ivonescimab (PD-1/VEGF Bispecific Antibody) Plus Radiofrequency Ablation for Multiple Advanced Tumors After PD-1 Therapy Failure (NCT07095803)Sheng Zhang2025-08-01
Multi-cohort, Single-arm, Phase II Study of the Efficacy and Side Effects of Cisplatin Plus Gemcitabine in the Treatment of PD1 Failure or Intensive Treatment of Some Rare Tumors (NCT07046650)Sheng Zhang2025-01-01

Track Sheng Zhang automatically

Every clearance here is in the API, with alerts when new ones post.